Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - To Learn More About CAM
National Center for Complementary and Alternative Medicine (NCCAM) The National Center for Complementary and Alternative Medicine (NCCAM) at the National Institutes of Health (NIH) facilitates research and evaluation of complementary and alternative practices, and provides information about a variety of approaches to health professionals and the public.NCCAM ClearinghousePost Office Box 7923 Gaithersburg, MD 20898–7923Telephone: 1–888–644–6226 (toll free) 301–519–3153 (for International callers)TTY (for deaf and hard of hearing callers): 1–866–464–3615Fax: 1–866–464–3616E-mail: firstname.lastname@example.org Web site: http://nccam.nih.govCAM on PubMedNCCAM and the NIH National Library of Medicine (NLM) jointly developed CAM on PubMed, a free and easy-to-use search tool for finding CAM-related journal citations. As a subset of the NLM's PubMed bibliographic database, CAM on PubMed features more than 230,000 references and abstracts for CAM-related articles from
Prostate Cancer Screening (PDQ®): Screening - Health Professional Information [NCI] - Summary of Evidence
Note: Separate PDQ summaries on Prevention of Prostate Cancer,Prostate Cancer Treatment,and Levels of Evidence for Cancer Screening and Prevention Studies are also available. Digital Rectal Examination and Prostate-Specific Antigen Benefits The evidence is insufficient to determine whether screening for prostate cancer with prostate-specific antigen (PSA) or digital rectal exam (DRE) reduces ...
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Introduction
Men in the United States get prostate cancer more than any other type of cancer except skin cancer. It is found mainly in older men. In the United States, about one out of five men will be diagnosed with prostate cancer. Most men diagnosed with prostate cancer do not die of it.Complementary and alternative medicine (CAM) is a form of treatment used in addition to (complementary) or instead of (alternative) standard treatments. CAM treatments generally are not considered standard medical approaches. Standard treatments go through a long and careful research process to prove they are safe and effective, but less is known about most types of CAM. CAM use among prostate cancer patients is reported to be common. CAM treatments used by prostate cancer patients include certain foods, dietary supplements, herbs, vitamins, and minerals. This PDQ CAM summary gives general information about using foods and dietary supplements to lower the risk of developing prostate cancer or for treating
Prostate Cancer Screening (PDQ®): Screening - Patient Information [NCI] - Changes to This Summary (08 / 22 / 2013)
The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above. Editorial changes were made to this summary.
Prostate Cancer Prevention (PDQ®): Prevention - Patient Information [NCI] - What is prevention?
WebMD discusses methods of preventing prostate cancer.
Genetics of Prostate Cancer (PDQ®): Genetics - Health Professional Information [NCI] - Prostate Cancer Risk Assessment
The purpose of this section is to describe current approaches to assessing and counseling patients about susceptibility to prostate cancer. Genetic counseling for men at increased risk of prostate cancer encompasses all of the elements of genetic counseling for other hereditary cancers. (Refer to the PDQ summary on Cancer Genetics Risk Assessment and Counseling for more information.) The components of genetic counseling include concepts of prostate cancer risk, reinforcing the importance of detailed family history, pedigree analysis to derive age-related risk, and offering participation in research studies to those individuals who have multiple affected family members.[1,2]Genetic testing for prostate cancer susceptibility is not available outside of the context of a research study. Families with prostate cancer can be referred to ongoing research studies; however, these studies will not provide individual genetic results to participants.Prostate cancer will affect an estimated one
Prostate Cancer, Nutrition, and Dietary Supplements (PDQ®): Complementary and alternative medicine - Patient Information [NCI] - Overview of CAM Use in Prostate Cancer
Studies of CAM use to treat prostate cancer have shown the following:Men who have prostate cancer are more likely to take dietary supplements than men who do not have prostate cancer.Prostate cancer patients with the healthiest eating habits (for example, eating lots of fish rich in omega-3 fatty acids and vegetables) are the most likely to take dietary supplements.Popular dietary supplements used by prostate cancer patients include lycopene, vitamin E, selenium, and saw palmetto.Reasons given by prostate cancer patients for using CAM treatments include boosting the immune system, improving quality of life, and lowering the risk of the cancer coming back.Studies of CAM use to lower the risk of developing prostate cancer or to prevent it from coming back have shown the following:A study of men with a family history of prostate cancer found that over half used vitamins or other dietary supplements, including those sold for prostate health or cancer prevention such as selenium, green
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Stage IV Prostate Cancer Treatment
OverviewStage IV prostate cancer is defined by the American Joint Committee on Cancer's TNM classification system:T4, N0, M0, any prostate-specific antigen (PSA), any Gleason.Any T, N1, M0, any PSA, any Gleason.Any T, any N, M1, any PSA, any Gleason.Extraprostatic extension with microscopic bladder neck invasion (T4) is included with T3a.Treatment selection depends on the following factors:Age.Coexisting medical illnesses.Symptoms.The presence of distant metastases (most often bone) or regional lymph node involvement only.The most common symptoms originate from the urinary tract or from bone metastases. Palliation of symptoms from the urinary tract with transurethral resection of the prostate (TURP) or radiation therapy and palliation of symptoms from bone metastases with radiation therapy or hormonal therapy are an important part of the management of these patients. Bisphosphonates may also be used for the management of bone
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - Treatment Option Overview for Prostate Cancer
Local treatment modalities are associated with prolonged disease-free survival for many patients with localized prostate cancer but are rarely curative in patients with locally extensive tumors. Because of clinical understaging using current diagnostic techniques, even when the cancer appears clinically localized to the prostate gland, some patients develop disseminated tumors after local therapy with surgery or radiation. Metastatic prostate cancer is currently not curable.Treatment options for each stage of prostate cancer are presented in Table 9.Table 9. Treatment Options by Stage for Prostate CancerStage (TNM Staging Criteria)Standard Treatment OptionsTURP = transurethral resection of the prostate.Stage I Prostate CancerWatchful waiting or active surveillanceRadical prostatectomyExternal-beam radiation therapy (EBRT)Interstitial implantation of radioisotopesStage II Prostate CancerWatchful waiting or active
Prostate Cancer Treatment (PDQ®): Treatment - Health Professional Information [NCI] - nci_ncicdr0000062910-nci-header
This information is produced and provided by the National Cancer Institute (NCI). The information in this topic may have changed since it was written. For the most current information, contact the National Cancer Institute via the Internet web site at http://cancer.gov or call 1-800-4-CANCER.Prostate Cancer Treatment